Dante Labs Genome Report Helps Single Mother Identify Her Children’s Rare Disease and Find Specialist Care
A Mother’s Search for Answers
For years, Susan lived with a quiet but persistent fear—one that surfaced every time her children suddenly collapsed without warning. What began as occasional, puzzling incidents soon became a recurring pattern that disrupted daily life. Her two children would experience sudden episodes of full-body muscle weakness, leaving them unable to stand, walk, or even support themselves. These episodes varied in duration, sometimes lasting only a few minutes, other times stretching into hours.
What made the situation even more confusing was what happened in between. Outside of these episodes, Susan’s children appeared perfectly healthy. They played, ran, and interacted just like any other children their age. To an outside observer—including many medical professionals—there seemed to be nothing wrong.
But Susan knew better.
When Symptoms Don’t Fit the System
Living in a small town in New Zealand, Susan did everything she could to find answers. She scheduled appointment after appointment, moving from one doctor to another, hoping that someone would recognize the symptoms and provide clarity. Each visit followed a similar pattern—routine blood tests, basic evaluations, and ultimately, no definitive findings.
The results consistently came back normal.
Without clear clinical evidence, her children’s condition was often minimized or misunderstood. Some doctors suggested that the symptoms might be stress-related. Others implied that the issue could be psychological. There were no referrals to specialists, no deeper diagnostic investigations, and no structured follow-up plans.
Over time, the lack of answers became as distressing as the condition itself.
Susan found herself in a difficult position—advocating for her children while simultaneously feeling dismissed by the very system meant to help them. The more she pushed for answers, the more she felt that attention shifted away from her children’s symptoms and toward questioning her concerns.
The Emotional Toll of Uncertainty
The experience took a significant emotional toll. Watching her children go from active and energetic to suddenly immobilized was deeply distressing. Each episode brought with it a sense of helplessness and fear—fear of the unknown, fear of worsening symptoms, and fear that something serious was being overlooked.
Susan described the frustration of repeatedly hearing that everything was “fine” when it clearly wasn’t. The gap between what she observed at home and what was documented in clinical settings created a growing sense of isolation.
“I watched my children go from running and playing to being unable to stand,” Susan recalled. “Every time I brought them in, the tests said they were fine. I started to feel like the system had decided I was the problem, not their symptoms.”
Despite the challenges, Susan remained determined. She refused to accept that there was no explanation.
Turning to Research and New Possibilities
With limited support from traditional medical pathways, Susan began conducting her own research. She explored medical journals, online communities, and rare disease resources, searching for any condition that matched her children’s symptoms.
This independent effort led her to consider genetic testing—specifically, whole genome sequencing.
Unlike standard diagnostic panels that focus on a limited number of genes associated with common or well-characterized conditions, whole genome sequencing offers a comprehensive analysis of an individual’s entire DNA. It has the potential to uncover rare genetic variants that might otherwise remain undetected.
For Susan, this approach represented a new path forward—one that could provide answers where conventional methods had failed.
A Critical Decision: Whole Genome Sequencing
Acting on her research, Susan decided to pursue whole genome sequencing for both of her children through Dante Labs. It was a significant step, both financially and emotionally. The decision was driven by hope—the hope that this advanced technology could finally reveal the underlying cause of her children’s mysterious condition.
The process involved analyzing the complete genetic code of each child, searching for variants that could explain their symptoms. Unlike targeted tests, which examine only specific genes, whole genome sequencing leaves no part of the DNA unexplored.
When the results arrived, they brought long-awaited clarity.
The Diagnosis: Periodic Paralysis
The genome reports identified pathogenic variants associated with periodic paralysis, an ultra-rare inherited condition that affects approximately one in 100,000 people. This disorder is characterized by episodes of muscle weakness or paralysis, often triggered by factors such as fluctuations in potassium levels, rest after physical activity, or certain dietary influences.
For Susan, the diagnosis was a turning point.
The condition explained the sudden, episodic nature of her children’s symptoms. It validated years of observations and concerns that had previously been dismissed. Most importantly, it provided a concrete medical explanation—something that had been missing for far too long.
The genetic variants responsible for the condition had been present since birth, silently influencing her children’s health without detection.
A Shift in Medical Response
Armed with the genome reports, Susan returned to her children’s medical team. This time, the reaction was markedly different.
The genetic findings offered clear, evidence-based insights that shifted the conversation. Neurologists began to take the case seriously, recognizing the clinical relevance of the diagnosis. Genetic specialists were brought in to further evaluate and confirm the findings.
The same symptoms that had once been questioned were now understood within a defined medical framework.
This shift opened the door to specialized care. Susan’s children were referred to clinicians with expertise in neuromuscular and genetic conditions. These specialists began working collaboratively to confirm the diagnosis, identify potential triggers for the episodes, and develop a comprehensive management plan.
Access to Specialized Care and Ongoing Support
With a diagnosis in place, Susan’s children gained access to the care they needed. Their medical team began focusing on proactive management strategies, including monitoring triggers, adjusting lifestyle factors, and exploring treatment options to reduce the frequency and severity of episodes.
The difference was transformative.
Instead of reacting to unexplained incidents, Susan and her children now had a structured plan supported by knowledgeable professionals. The uncertainty that had once defined their experience was replaced with informed decision-making and targeted care.
Equally important was the sense of validation. After years of feeling unheard, Susan finally felt that her concerns were recognized and respected.
“For years, no one listened,” she said. “Now the best specialists are paying attention. Now my kids have a name for what is happening to them—and a medical team that believes it.”
The Broader Impact of Genomic Technology
Susan’s story highlights the growing role of genomic technology in modern healthcare. Traditional diagnostic approaches, while effective in many cases, can fall short when dealing with rare or complex conditions. Whole genome sequencing offers a more comprehensive alternative, capable of uncovering hidden genetic causes that might otherwise go undetected.
Andrea Riposati, co-founder and CEO of Dante Labs, emphasized this point. He noted that many individuals live with unanswered medical questions that conventional technologies have not yet resolved. Whole genome sequencing provides an unbiased and complete view of a person’s genetic code, enabling deeper insights into their health.
“Behind every genome is a person living inside questions that traditional technologies have not yet answered,” he said. “The genome provides an unbiased view of every person’s code. We built this company for families like hers.”
A Story of Persistence and Hope
Today, Susan and her children are navigating a new chapter—one defined not by uncertainty, but by understanding. While periodic paralysis remains a challenging condition, the presence of a diagnosis has fundamentally changed their journey.
They now have access to specialists, a clearer understanding of triggers, and a roadmap for managing the condition. The sense of isolation that once weighed heavily on Susan has been replaced by a network of support and expertise.
Her story serves as a powerful reminder of the importance of persistence in the face of medical uncertainty. It also underscores the need for healthcare systems to listen carefully to patients and caregivers, especially when symptoms do not fit neatly into conventional frameworks.
Protecting Privacy, Sharing Impact
To protect her family’s privacy, Susan’s name has been anonymized. However, her experience resonates with countless families facing similar challenges—those navigating rare conditions, seeking answers, and advocating for their loved ones.
In the end, what began as years of unanswered questions has become a story of clarity, validation, and hope. Through determination, research, and the power of advanced genomic technology, Susan was able to uncover the truth behind her children’s condition—transforming not only their medical care, but their future.
About Dante Labs
We are a leading provider of AI-powered genomics solutions, dedicated to accelerating discovery and improving patient outcomes through advanced computational biology tools.
